PharmaSeq

Home Company News & Events Press Releases 2015 PharmaSeq Licenses p-Chips to Summate Technologies for Tagging Surgical Instruments

Press Releases

PharmaSeq Licenses p-Chips to Summate Technologies for Tagging Surgical Instruments

Monmouth Junction, NJ, and Newburyport, MA, June 19, 2015.  PharmaSeq, Inc., announced today that it has signed a definitive agreement to license its patented p-Chip® microtransponders to Summate Technologies, Inc. Summate, which has incorporated p-Chips into its proprietary TagTape® labels, is offering hospitals and clinics a complete information management system to tag and track surgical instruments and related devices throughout their entire cycle of use. Unlike other systems, TagTape can be easily applied to very small instruments and can be read in situations where barcodes typically fail to read. TagTape and its associated Simplicity™ web-based software will increase efficiencies and lower operating costs by saving instrument tray re-assembly time, reducing lost instruments and identifying actual operating room usage to remove obsolete instruments from trays. TagTape has been six-sigma-certified for sterilization validation under currently practiced methodologies. The Summate solution will also be used to tag medical device sets and automate usage communication to vendors who, in turn, can monitor the set’s stock levels and instrument usage to improve patient billing accuracy.

According to the license agreement, PharmaSeq will supply p-Chips to Summate exclusively for incorporation into its TagTape labels. Summate is offering customers complete systems that include (1) TagTape, (2) p-Chip readers manufactured by PharmaSeq and (3) Simplicity, Summate’s cloud-based tracking system that integrates inventory, work flow and reporting into a seamless package. Summate will also provide training, service and support for its customers. 

Todd Rosseau, COO of Summate, observed, “It’s hard to manage what you can’t measure. Hospitals typically manage hundreds of thousands of instruments through creating paper lists and isolated spreadsheets. The use of Summate’s Simplicity web-based software will provide for faster, more accurate assembly of instrument kits and trays. For the first time, hospitals will be able to actually account for usage in the operating room. The new technology will also allow administrators to measure and manage staff productivity. All of this will lower costs for the customers. Other management systems do not rely on individually tagged instruments thus the use of surgical tools cannot be monitored at the unit level.”

Commenting on the license agreement, Richard G. Morris, Ph.D., CEO of PharmaSeq, remarked, “The granting of a license to Summate represents a significant milestone for us as it validates our business model of partnering with a company to bring p-Chip technology to market in a field where complementary expertise adds value for customers. Summate has demonstrated strong economic incentives for adaptation. We anticipate that Summate’s approach will rapidly become a standard for hospitals.”

For further information, please contact Dr. Morris at (732) 355-0100 or rmorris@pharmaseq.com, or Mr. Rosseau at 844-SUMMATE or todd.rosseau@summate.net

PharmaSeq, Inc.
11 Deer Park Drive, Suite 104
Monmouth Junction, NJ 08852

Summate Technologies, Inc.
24 Rawson Avenue
Newburyport, MA 01950
www.summate.net


Download as PDF

 

 

Home Company News & Events Press Releases 2015 PharmaSeq Licenses p-Chips to Summate Technologies for Tagging Surgical Instruments